Related Experiment Video
Updated: Jul 5, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Resolution of Marked Bradycardia Following Angioplasty
Khudheeja A Ahmed1, Juwayria Ahmed1, Mohammed Habeeb Ahmed2
1Department of Research, Kaaj Healthcare, San Jose, USA.
Insights
Bradycardia symptoms resolved after coronary angioplasty, suggesting coronary artery disease (CAD) may cause bradycardia. This highlights the need to evaluate for CAD before pacemaker implantation in bradycardic patients.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Bradycardia management typically involves conservative measures or pacemaker implantation.
- Coexistence of bradycardia and coronary artery disease (CAD) presents complex clinical challenges.
- Conventional treatment protocols may not always address underlying causes of bradycardia in CAD patients.
Observation:
- This case report details an unusual instance where bradycardia and associated symptoms resolved post-coronary angioplasty.
- The patient's bradycardia was linked to underlying coronary artery disease.
- Resolution of bradycardia occurred without direct intervention for the arrhythmia itself.
Findings:
- Coronary angioplasty led to the complete resolution of bradycardia in this patient.
- This suggests a potential causal link between significant coronary artery disease and bradycardia.
- The findings challenge the assumption that bradycardia always necessitates pacemaker implantation.
Implications:
- Comprehensive evaluation for underlying coronary artery disease is crucial in patients with bradycardia before pacemaker implantation.
- Considering CAD as a potential cause for bradycardia may prevent unnecessary pacemaker procedures.
- This case advocates for a more individualized and integrated approach to managing patients with concurrent bradycardia and CAD.
Abstract:
Bradycardia, a condition commonly managed conservatively and, subsequently, with pacemaker implantation presents a unique challenge when coexisting with coronary artery disease (CAD). This case report delves into an unusual scenario where bradycardia and its related symptoms resolved following coronary angioplasty. Our goal is to contribute valuable data to the argument for a comprehensive evaluation of bradycardic patients for underlying CAD prior to considering pacemaker implantation. This approach aims to prevent unnecessary pacemaker implantations and offers insights into the optimal management of patients presenting with both arrhythmia and CAD. The unusual resolution of bradycardia in this case underscores the importance of considering CAD as a possible underlying factor in bradycardic patients, prompting a reevaluation of conventional treatment protocols. By documenting this exceptional case, the authors advocate a more nuanced and individualized treatment strategy in the management of bradycardia, emphasizing the need to assess and address CAD as part of the diagnostic workup.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

